The Impact of the COVID-19 Pandemic on Cancer Patients

Osama M Al-Quteimat, Amer Mustafa Amer, Osama M Al-Quteimat, Amer Mustafa Amer

Abstract

In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an outbreak of coronavirus disease 2019 (COVID-19). Severe complications have been reported to occur in 33% of patients with COVID-19 and include acute respiratory distress syndrome, acute renal failure, acute respiratory injury, septic shock, and severe pneumonia. Currently, there is no specific treatment or approved vaccine against COVID-19 and many clinical trials are currently investigating potential medications to treat COVID-19. The immunosuppressed status of some cancer patients (whether caused by the disease itself or the treatment) increases their risk of infection compared with the general population. This short review aims to focus on the impact of COVID-19 on a cancer patient and discuss management options and recommendation in addition to highlighting the currently available clinical guidelines and resources.

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. International Pharmaceutical Federation. Coronavirus SARS-CoV-2 outbreak: information and guidelines for pharmacists and the pharmacy workforce. Febuary 12, 2020.
    1. Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioSci Trends. 2020;14:72–73.
    1. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337.
    1. Zhang H, Huang Y, Xie C. The treatment and outcome of a lung cancer patient infected with SARS-CoV-2. J Thorac Oncol. 2020. Available at: .
    1. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21:E181.
    1. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020. Available at: .
    1. British Columbia Caner Agency. COVID-19 and cancer treatments—Information for patients. March 23, 2020. Available at: Accessed March 27, 2020.
    1. Cancer Council Australia. Information and support regarding cancer and COVID-19. Available at: Accessed March 27, 2020.
    1. National Institute for Health and Care Excellence. COVID-19 rapid guideline: delivery of systemic anticancer treatments. March 20, 2020. Available at: Accessed March 26, 2020.
    1. European Society of Medical Oncology. COVID-19 and cancer. Available at: Accessed March 26, 2020.
    1. Royal College of Radiologists. Repository of advisory documents for cancer treatment during the coronavirus (COVID-19) pandemic. Available at: Accessed March 26, 2020.
    1. Ueda M, Martins R, Hendrie PC, et al. Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal. J Natl Compr Canc Netw. 2020;18:1–4.
    1. Lung Cancer Study Group, Chinese Thoracic Society, Chinese Medical Association, Chinese Respiratory Oncology Collaboration. Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version). Chin J Tuberc Respir Dis. 2020;43:E031.
    1. Kutikov A, Weinberg DS, Edelman MJ, et al. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med. 2020. Doi: 10.7326/M20-1133.
    1. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020. Available at: 10.1038/s41571-020-0362-6.
    1. Taylor NP. Dana-Farber, MD Anderson ban all business travel over COVID-19. Fiercebiotech. March 6, 2020. Available at: Accessed March 8, 2020.
    1. American College of Surgeons. Ethical framework for the allocation of resources in the event of shortages. Available at: Accessed April 1, 2020.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit